Pharmacokinetics of cefotetan in patients with end-stage renal failure on maintenance dialysis. 1986

M J Browning, and H A Holt, and L O White, and S T Chapman, and R A Banks, and D S Reeves, and R A Yates

The pharmacokinetics of a single intravenous dose of cefotetan were studied in 17 volunteer patients with end-stage renal failure, requiring intermittent haemodialysis in 12 cases or undergoing continuous ambulatory peritoneal dialysis in 5 cases. Between haemodialysis the mean plasma elimination half life was 20.4 h (S.E.M. +/- 2.1). This decreased to 7.5 h (S.E.M. +/- 0.6) during haemodialysis. In patients treated by continuous ambulatory peritoneal dialysis the mean plasma elimination half life was 15.5 h (S.E.M. +/- 1.9). Small amounts of cefotetan (5-9% of the administered dose) were recovered in the peritoneal dialysates removed over the 24 h following the dose.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015313 Cefotetan A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms. Apacef,Apatef,Cefotan,Cefotetan Disodium,Cefotetan Disodium Salt,Ceftotan,ICI-156834,YM-09330,Disodium Salt, Cefotetan,Disodium, Cefotetan,ICI 156834,ICI156834,Salt, Cefotetan Disodium,YM 09330,YM09330

Related Publications

M J Browning, and H A Holt, and L O White, and S T Chapman, and R A Banks, and D S Reeves, and R A Yates
January 2000, Przeglad lekarski,
M J Browning, and H A Holt, and L O White, and S T Chapman, and R A Banks, and D S Reeves, and R A Yates
October 1986, The Japanese journal of antibiotics,
M J Browning, and H A Holt, and L O White, and S T Chapman, and R A Banks, and D S Reeves, and R A Yates
January 2015, Pakistan journal of medical sciences,
M J Browning, and H A Holt, and L O White, and S T Chapman, and R A Banks, and D S Reeves, and R A Yates
July 1990, Scandinavian journal of gastroenterology,
M J Browning, and H A Holt, and L O White, and S T Chapman, and R A Banks, and D S Reeves, and R A Yates
November 1969, Journal of the Iowa Medical Society,
M J Browning, and H A Holt, and L O White, and S T Chapman, and R A Banks, and D S Reeves, and R A Yates
January 1996, Nephron,
M J Browning, and H A Holt, and L O White, and S T Chapman, and R A Banks, and D S Reeves, and R A Yates
May 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M J Browning, and H A Holt, and L O White, and S T Chapman, and R A Banks, and D S Reeves, and R A Yates
September 2010, Kardiologia polska,
M J Browning, and H A Holt, and L O White, and S T Chapman, and R A Banks, and D S Reeves, and R A Yates
September 2013, The Journal of the Michigan Dental Association,
M J Browning, and H A Holt, and L O White, and S T Chapman, and R A Banks, and D S Reeves, and R A Yates
January 1990, Therapeutic drug monitoring,
Copied contents to your clipboard!